Items tagged with Advocacy
Bangkok statement on TB community-led monitoring (post with simple image)
Joint position statement and global solidarity appeal from TB communities to all TB stakeholders
1/4/6x24 Campaign: Community training materials (post with simple image)
Materials designed to equip civil society and community-based organizations with the information they need to advocate for equitable access to the short-course treatment and prevention regimens at the heart of the 1/4/6×24 Campaign.
Statement by Stop TB Partnership on World AIDS Day 2022 (post with simple image)
To end HIV/AIDS and TB, we need to ‘equalize’ global commitment, financial resources and attention between the two diseases.
World AIDS Day: Equalize – addressing inequalities to End TB and AIDS! (post with simple image)
The World Health Organization is joining partners in commemorating World AIDS Day 2022, and calls on global leaders and citizens to equalize access to essential HIV and TB services, particularly for key and vulnerable populations.
GFAN selected for UN High-Level Meeting Affected Communities and Civil Society Platform (post with simple image)
GFAN is selected to coordinate the Affected Communities and Civil Society Platform for the 2023 UN High-Level Meeting on TB. Applications are now being accepted for lead consultant(s) to support this work (Deadline: 5 January 2023).
GCTA report launched: Innovative TB Community Service Delivery during the COVID-19 Pandemic (post with simple image)
Innovative TB Community Service Delivery during the COVID-19 Pandemic: Best Practices and Lessons Learned from Cambodia, India, Indonesia, and Kenya
Urgent action necessary to improve equitable access to bedaquiline-based regiments and achieve 1/4/6×24 (post with simple image)
Advocates urge Johnson & Johnson to correct its course and stop blocking entry of generic versions of bedaquiline into the global market and into countries.
India must reject Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug bedaquiline (post with simple image)
Médecins Sans Frontières urges the Indian Patent Office to reject the secondary patent application filed by Johnson & Johnson to prevent the company from extending its monopoly on bedaquiline beyond the primary patent’s expiry in July 2023.
WHO announces plans to establish a TB Vaccine Accelerator Council (post with simple image)
The Council will facilitate the licensing and use of effective novel TB vaccines catalysing high-level alignment between funders, global agencies, governments and end users in identifying and overcoming barriers to TB vaccine development.
Updates from the 1/4/6x24 Campaign (post with simple image)
A few recent Campaign updates from Treatment Action Group and allies.
Contact [email protected] for more information on how to be part of the 1/4/6x24 Campaign.
Page 117 of 127 · Total posts: 0
←First 116 117 118 Last→